Introduction
Bare metal stent (BMS) market is anticipated to witness an impressive CAGR during the forecast period. A bare metal stent is a small metal mesh tube that is inserted into the artery to keep it open and reduce the risk of a heart attack. BMS is used to treat coronary artery diseases and peripheral artery diseases. The increasing prevalence of cardiovascular diseases, technological advancements in the field of BMS, and rising geriatric population are the major factors that drive the growth of the bare metal stent market.
Market Dynamics
Drivers
The increasing prevalence of cardiovascular diseases is the major factor driving the growth of the bare metal stent market. According to the World Health Organization (WHO), globally, around XX million deaths occurred due to cardiovascular diseases in 20XX. Additionally, the technological advancements in BMS are expected to boost the market growth. For instance, the introduction of drug-eluting stents, which offer better results than bare metal stents, is expected to boost the growth of the bare metal stent market. Moreover, the rising geriatric population and the increasing number of lifestyle diseases are some of the key factors that are expected to drive the growth of the BMS market.
Restraints
The high cost of BMS is the major factor that is expected to restrain the growth of the bare metal stent market. Additionally, the presence of stringent regulatory guidelines is another factor that is expected to hamper the growth of the BMS market.
Opportunities
The increasing demand for minimally-invasive procedures is expected to drive the growth of the bare metal stent market. Furthermore, the increasing adoption of medical devices in developing countries is expected to create lucrative opportunities for the market players.
Market Analysis
The global bare metal stent market is segmented based on type, application, and region. On the basis of type, the market is segmented into type A, type B, and others. On the basis of type, the market is segmented into application A, application B, and others.
Regional Analysis
Geographically, the global bare metal stent market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global BMS market due to the increasing prevalence of cardiovascular diseases, the presence of major market players, and the increasing adoption of medical devices. The Asia Pacific region is anticipated to witness significant growth due to the increasing geriatric population and the increasing demand for minimally-invasive procedures.
Future Trends
The increasing investment in research and development activities and the introduction of new products are expected to drive the growth of the BMS market in the forecast period. Additionally, the increasing focus on mergers and acquisitions is expected to create lucrative opportunities for the market players.
Qualitative Insights
The major market players are focusing on new product launches and acquisitions to strengthen their market position. For instance, in March 20XX, Abbott Vascular launched a new version of its Absorb bioresorbable scaffold. Additionally, in December 20XX, Medtronic launched the Resolute Onyx drug-eluting stent for the treatment of coronary artery diseases. Moreover, Boston Scientific, Terumo, Biosensors, B.Braun, and MicroPort are focusing on new product launches and partnerships to expand their market share.
Porter’s Five Force Analysis
The competitive rivalry among the major market players is high. The market is dominated by a few major players, such as Abbott Vascular, Medtronic, Boston Scientific, Terumo, Biosensors, B.Braun, and MicroPort. Additionally, the threat of new entrants is low as the market is highly consolidated. Moreover, the bargaining power of suppliers is low due to the presence of several suppliers in the market. The bargaining power of buyers is low as the buyers have limited choices. Furthermore, the threat of substitutes is low as the products offered by the market players are unique.
Strategies Adopted in the Last 4 Years
Abbott Vascular has adopted various strategies such as mergers and acquisitions, product launches, and partnerships. In April 20XX, Abbott Vascular acquired Evalve, Inc., a US-based medical device company. Additionally, in April 20XX, Abbott Vascular launched the MitraClip G4 device, a minimally-invasive device designed to treat mitral valve regurgitation. Moreover, Boston Scientific, Terumo, Biosensors, B.Braun, and MicroPort are focusing on mergers and acquisitions, new product launches, and partnerships to expand their market share.
Five more new companies
Some of the new companies in the bare metal stent market are Lumenis, Misonix, InspireMD, NIPRO Medical Corporation, and Endologix. Lumenis is focusing on product launches and partnerships to strengthen its market position. For instance, in February 20XX, Lumenis launched the Lumenis Unison, a new imaging platform. Similarly, Misonix is focusing on new product launches and partnerships to expand its market share. For instance, in October 20XX, Misonix launched the SonicOne surgical aspirator system. Moreover, InspireMD, NIPRO Medical Corporation, and Endologix are focusing on new product launches, partnerships, and acquisitions to strengthen their market position.
Bare metal stent (BMS) market is anticipated to witness an impressive CAGR during the forecast period. A bare metal stent is a small metal mesh tube that is inserted into the artery to keep it open and reduce the risk of a heart attack. BMS is used to treat coronary artery diseases and peripheral artery diseases. The increasing prevalence of cardiovascular diseases, technological advancements in the field of BMS, and rising geriatric population are the major factors that drive the growth of the bare metal stent market.
Market Dynamics
Drivers
The increasing prevalence of cardiovascular diseases is the major factor driving the growth of the bare metal stent market. According to the World Health Organization (WHO), globally, around XX million deaths occurred due to cardiovascular diseases in 20XX. Additionally, the technological advancements in BMS are expected to boost the market growth. For instance, the introduction of drug-eluting stents, which offer better results than bare metal stents, is expected to boost the growth of the bare metal stent market. Moreover, the rising geriatric population and the increasing number of lifestyle diseases are some of the key factors that are expected to drive the growth of the BMS market.
Restraints
The high cost of BMS is the major factor that is expected to restrain the growth of the bare metal stent market. Additionally, the presence of stringent regulatory guidelines is another factor that is expected to hamper the growth of the BMS market.
Opportunities
The increasing demand for minimally-invasive procedures is expected to drive the growth of the bare metal stent market. Furthermore, the increasing adoption of medical devices in developing countries is expected to create lucrative opportunities for the market players.
Market Analysis
The global bare metal stent market is segmented based on type, application, and region. On the basis of type, the market is segmented into type A, type B, and others. On the basis of type, the market is segmented into application A, application B, and others.
Regional Analysis
Geographically, the global bare metal stent market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global BMS market due to the increasing prevalence of cardiovascular diseases, the presence of major market players, and the increasing adoption of medical devices. The Asia Pacific region is anticipated to witness significant growth due to the increasing geriatric population and the increasing demand for minimally-invasive procedures.
Future Trends
The increasing investment in research and development activities and the introduction of new products are expected to drive the growth of the BMS market in the forecast period. Additionally, the increasing focus on mergers and acquisitions is expected to create lucrative opportunities for the market players.
Qualitative Insights
The major market players are focusing on new product launches and acquisitions to strengthen their market position. For instance, in March 20XX, Abbott Vascular launched a new version of its Absorb bioresorbable scaffold. Additionally, in December 20XX, Medtronic launched the Resolute Onyx drug-eluting stent for the treatment of coronary artery diseases. Moreover, Boston Scientific, Terumo, Biosensors, B.Braun, and MicroPort are focusing on new product launches and partnerships to expand their market share.
Porter’s Five Force Analysis
The competitive rivalry among the major market players is high. The market is dominated by a few major players, such as Abbott Vascular, Medtronic, Boston Scientific, Terumo, Biosensors, B.Braun, and MicroPort. Additionally, the threat of new entrants is low as the market is highly consolidated. Moreover, the bargaining power of suppliers is low due to the presence of several suppliers in the market. The bargaining power of buyers is low as the buyers have limited choices. Furthermore, the threat of substitutes is low as the products offered by the market players are unique.
Strategies Adopted in the Last 4 Years
Abbott Vascular has adopted various strategies such as mergers and acquisitions, product launches, and partnerships. In April 20XX, Abbott Vascular acquired Evalve, Inc., a US-based medical device company. Additionally, in April 20XX, Abbott Vascular launched the MitraClip G4 device, a minimally-invasive device designed to treat mitral valve regurgitation. Moreover, Boston Scientific, Terumo, Biosensors, B.Braun, and MicroPort are focusing on mergers and acquisitions, new product launches, and partnerships to expand their market share.
Five more new companies
Some of the new companies in the bare metal stent market are Lumenis, Misonix, InspireMD, NIPRO Medical Corporation, and Endologix. Lumenis is focusing on product launches and partnerships to strengthen its market position. For instance, in February 20XX, Lumenis launched the Lumenis Unison, a new imaging platform. Similarly, Misonix is focusing on new product launches and partnerships to expand its market share. For instance, in October 20XX, Misonix launched the SonicOne surgical aspirator system. Moreover, InspireMD, NIPRO Medical Corporation, and Endologix are focusing on new product launches, partnerships, and acquisitions to strengthen their market position.
Key Benefits of the Report
- This study presents the analytical depiction of the Bare Metal Stent Market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the Bare Metal Stent Market share.
- The current market is quantitatively analyzed to highlight the Bare Metal Stent Market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed Bare Metal Stent Market analysis based on competitive intensity and how the competition will take shape in coming years
Bare Metal Stent Market Report Highlights
| Aspects | Details |
 By Types |
|
 By Applications |
|
 By Region |
|
 Key Market Players | Biosensors, Boston Scientific, B.Braun, MicroPort, Medtronic, Biotronik, Abbott Vascular, Terumo |
Loading Table Of Content...
